~ Antenatal Corticosteroid ~
1. Benefits of prenatal corticosteroid therapy:
Ÿ The greatest benefit is achieved if more
than 24 hrs and less than 7 days.
Ÿ Infants born within 24 hrs or more than
7 days also show:
i mortality
i incidence or severity of respiratory
distress syndrome
i intraventricular hemorrhage
i requirement for oxygen and ventilatory
support
i neonatal costs and length of stay in
NICU
2. Indications:
Ÿ The most significant benefit is seen
between 24 and 34 weeks of gestation
Ÿ All pregnant women between 24 and 34
weeks of gestation should be considered candidates for
corticosteroid therapy
3. Contraindications:
Ÿ Any clinical suspicion or evidence of
intrauterine infection
Ÿ Caution should be exercised in
coexisting conditions maybe adversely affected:
- severe hypertensive disorders in pregnancy
- intrauterine growth restriction
- diabetes mellitus
- Rh isoimmunization
- peptic ulcer disease
4. Recommended regimens for fetal maturation:
Ÿ Betamethasone: 12mg given im. every 24
hrs ´ 2 doses
Ÿ Dexamethasone: 6mg given im. every 12
hrs ´ 4 doses
Ÿ Prenatal Corticosteroids should be
administered even if delivery is expected to occur before
the second dose.
Antenatal corticosteroids
outweight the potential risk: reduction in the risk of RDS but also a
substantial reduction in mortality and IVH
all fetus between 24 and 34 weeks gestation at risk
eligible for therapy with tocolytics should also be eligible for treatment
with antenatal corticosteriods
treatment consists of two dose of 12 mg of betamethasone given
intramuscularly 24 hours apart or four doses of 6 mg dexamethasone given
intramuscularly 12 hours apart. Optimal benefit begins 24 hours after
initiation of therapy and lasts 7 days.
Treatment for less 24 hours is still associated with significant reduction
in neonatalmortaility, RDS, and IVH.
PPROM < 30-32 weeks’ gestation in the absence of clinical
choriomamnionitis, corticosteriod is recommended because of the high risk of
IVH at these early gestational ages.
In complicated pregnancies where delivery prior to 34 weeks’ gestation is
likely, antenatal corticosteriod use is recommended unless there is evidence
that corticosteriods will have an adverse effect on the mother or delivery is
imminent.
|